Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury.
Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury.
复制标题
DOI:
10.1053/j.gastro.2009.05.009
复制
发表时间:
2009-08
期刊:
影响因子:
29.4
通讯作者:
DeLeve LD
中科院分区:
文献类型:
--
作者:
Harb R;Xie G;Lutzko C;Guo Y;Wang X;Hill CK;Kanel GC;DeLeve LD
Damage to hepatic sinusoidal endothelial cells (SEC) initiates sinusoidal obstruction syndrome (SOS), which is most commonly a consequence of myeloablative chemo-irradiation or ingestion of pyrrolizidine alkaloids such as monocrotaline (Mct). This study examines whether SEC are of bone marrow origin, whether bone marrow repair can be a determinant of severity of liver injury and whether treatment with progenitor cells is beneficial. Mct-treated female rats received infusion of male whole bone marrow or CD133+ cells at the peak of sinusoidal injury. The y-chromosome was identified in isolated SEC by fluorescent in situ hybridization. Bone marrow suppression was induced by irradiation of both lower extremities with shielding of the abdomen. SEC in uninjured liver have both hematopoietic (CD45, CD33) and endothelial (CD31) markers. After Mct-induced SOS, infusion of bone marrow derived CD133+ progenitor cells replaces more than one-quarter of SEC. All CD133+ cells recovered from the SEC fraction after injury are CD45+. CD133+/45+ progenitors also repaired central vein endothelium. Mct suppresses CD133+/CD45+ progenitors in bone marrow by 50% and in the circulation by 97%. Irradiation-induced bone marrow suppression elicited SOS from a sub-toxic dose of Mct, whereas infusion of bone marrow during the necrotic phase of SOS nearly eradicates histological features of SOS. SEC have both hematopoietic and endothelial markers. Bone marrow-derived CD133+/CD45+ progenitors replace SEC and central vein endothelial cells after injury. Toxicity to bone marrow progenitors impairs repair and contributes to the pathogenesis of SOS, whereas timely infusion of bone marrow has therapeutic benefit.
登录
查看更多内容
影响因子:
56.9
作者:
Asahara, T;Murohara, T;Isner, JM
通讯作者:
Isner, JM
影响因子:
20.3
作者:
Shi, Q;Rafii, S;Hammond, WP
通讯作者:
Hammond, WP
DOI:
10.1073/pnas.0604203103
发表时间:
2006-08-29
影响因子:
11.1
作者:
Bailey, Alexis S.;Willenbring, Holger;Fleming, William H.
通讯作者:
Fleming, William H.
影响因子:
3.6
作者:
Kienstra, Kirsten A.;Jackson, Kathyjo A.;Hirschi, Karen K.
通讯作者:
Hirschi, Karen K.
影响因子:
29.4
作者:
DeLeve, LD;Wang, XD;Tokes, ZA
通讯作者:
Tokes, ZA